Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers
ObjectivesDespite decades of research using animals to develop pharmaceutical treatments for patients who had a stroke, few therapeutic options exist. The vast majority of interventions successful in preclinical animal studies have turned out to have no efficacy in humans or to be harmful to humans....
Main Authors: | Pandora Pound, Rebecca Ram |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Open Science |
Online Access: | https://openscience.bmj.com/content/4/1/e100041.full |
Similar Items
-
Can prospective systematic reviews of animal studies improve clinical translation?
by: Pandora Pound, et al.
Published: (2020-01-01) -
Are Animal Models Needed to Discover, Develop and Test Pharmaceutical Drugs for Humans in the 21st Century?
by: Pandora Pound
Published: (2020-12-01) -
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
by: Pandora Pound, et al.
Published: (2018-11-01) -
Translating Cultural References in Japanese Animation Films: The Case of Spirited Away
by: Kaori Asakura
Published: (2019) -
Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions.
by: Pandora Pound, et al.
Published: (2018-01-01)